These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10582786)

  • 41. Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial.
    Hassan A; Shehata N; Wahba A
    Hum Fertil (Camb); 2017 Apr; 20(1):37-42. PubMed ID: 27825272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oligoovulatory and anovulatory cycles in women with polycystic ovary syndrome (PCOS): what's the difference?
    Burgers JA; Fong SL; Louwers YV; Valkenburg O; de Jong FH; Fauser BC; Laven JS
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E485-9. PubMed ID: 20843954
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ovarian stimulation with low-dose pure follicle-stimulating hormone in polycystic ovarian syndrome anovulatory patients: effect of long-term pretreatment with gonadotrophin-releasing hormone analogue.
    Vegetti W; Testa G; Ragni G; Parazzini F; Crosignani PG
    Gynecol Obstet Invest; 1998; 45(3):186-9. PubMed ID: 9565144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic ultra-low dose follicle-stimulating hormone regimen for patients with polycystic ovary syndrome: one click, one follicle, one pregnancy.
    Orvieto R; Homburg R
    Fertil Steril; 2009 Apr; 91(4 Suppl):1533-5. PubMed ID: 18990384
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol.
    Balasch J; Fábregues F; Creus M; Casamitjana R; Puerto B; Vanrell JA
    J Assist Reprod Genet; 2000 Nov; 17(10):561-5. PubMed ID: 11209536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Optimal Ovulation Induction in Polycystic Ovary Syndrome Resistant to Clomiphene Citrate or Letrozole.].
    Chen Y; Zhang D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):874-877. PubMed ID: 28598116
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urofollitropin and ovulation induction.
    van Wely M; Yding Andersen C; Bayram N; van der Veen F
    Treat Endocrinol; 2005; 4(3):155-65. PubMed ID: 15898821
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility.
    Mulders AG; Eijkemans MJ; Imani B; Fauser BC
    Reprod Biomed Online; 2003 Sep; 7(2):170-8. PubMed ID: 14567885
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Contribution of human menopausal gonadotropins purified as to their FSH content in anovulatory sterility presenting a difficult treatment problem].
    Emperaire JC; Ruffié A; Audebert AJ
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(5):621-6. PubMed ID: 3117873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.
    Dale PO; Tanbo T; Haug E; Abyholm T
    Hum Reprod; 1992 Sep; 7(8):1085-9. PubMed ID: 1400931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
    Zaidi J; Jacobs H; Campbell S; Tan SL
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens.
    van Santbrink EJ; Fauser BC
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3597-602. PubMed ID: 9360513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppression of LH during ovarian stimulation: effects differ in cycles stimulated with purified urinary FSH and recombinant FSH.
    Fleming R; Rehka P; Deshpande N; Jamieson ME; Yates RW; Lyall H
    Hum Reprod; 2000 Jul; 15(7):1440-5. PubMed ID: 10875848
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of metformin and clomiphene citrate therapy for induction of ovulation in the polycystic ovary syndrome.
    Baran S; Api M; Goksedef BP; Cetin A
    Arch Gynecol Obstet; 2010 Oct; 282(4):439-43. PubMed ID: 20473763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sequential step-up and step-down dose regimen: an alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome.
    Hugues JN; Cédrin-Durnerin I; Avril C; Bulwa S; Hervé F; Uzan M
    Hum Reprod; 1996 Dec; 11(12):2581-4. PubMed ID: 9021354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ovulation induction with low-dose follicle-stimulating hormone in women with the polycystic ovary syndrome.
    Dale O; Tanbo T; Lunde O; Abyholm T
    Acta Obstet Gynecol Scand; 1993 Jan; 72(1):43-6. PubMed ID: 8382432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome.
    Dale PO; Tanbo T; Haug E; Abyholm T
    Hum Reprod; 1998 Mar; 13(3):567-70. PubMed ID: 9572412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of total testosterone for pregnancy during treatment in patients with clomiphene-citrate-resistant polycystic ovary syndrome: a pilot study.
    Li C; Cheng J; Wang J; Xue Y; Huang Z; Zhang S; Lv J
    Arch Gynecol Obstet; 2011 Sep; 284(3):757-64. PubMed ID: 21614496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ovulatory disorders in women with polycystic ovary syndrome.
    Franks S; Adams J; Mason H; Polson D
    Clin Obstet Gynaecol; 1985 Sep; 12(3):605-32. PubMed ID: 3933879
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The predictive value of circulating anti-Müllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study.
    Mahran A; Abdelmeged A; El-Adawy AR; Eissa MK; Shaw RW; Amer SA
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4170-5. PubMed ID: 23979947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.